Advertisement
BDX vs RMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a StrongBuy and RMD is a StrongBuy.
Momentum Indicator for BDX turns positive, indicating new upward trend
BDX saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In 57 of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at 55%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for BDX just turned positive on October 09, 2026. Looking at past instances where BDX's MACD turned positive, the stock continued to rise in 23 of 46 cases over the following month. The odds of a continued upward trend are 50%.
BDX moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BDX crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +3.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDX advanced for three days, in 133 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.
The Aroon Indicator entered an Uptrend today. In 106 of 218 cases where BDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
BDX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. BDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.168) is normal, around the industry mean (4.961). P/E Ratio (58.536) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (1.107) is also within normal values, averaging (4.143). BDX has a moderately high Dividend Yield (0.022) as compared to the industry average of (0.005). P/S Ratio (2.290) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
RMD in upward trend: 10-day moving average broke above 50-day moving average on October 14, 2026
The 10-day moving average for RMD crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on RMD as a result. In 62 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for RMD just turned positive on October 08, 2026. Looking at past instances where RMD's MACD turned positive, the stock continued to rise in 25 of 39 cases over the following month. The odds of a continued upward trend are 64%.
RMD moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for RMD moved above the 200-day moving average on October 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in 181 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Aroon Indicator entered an Uptrend today. In 133 of 218 cases where RMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
RMD broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. RMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 40 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.393) is normal, around the industry mean (4.961). P/E Ratio (23.515) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (4.143). Dividend Yield (0.011) settles around the average of (0.005) among similar stocks. P/S Ratio (5.896) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
BDX | RMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 78 | 100 | |
SMR RATING 1..100 | 85 | 40 | |
PRICE GROWTH RATING 1..100 | 9 | 40 | |
P/E GROWTH RATING 1..100 | 7 | 61 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RMD's Valuation (66) in the Medical Specialties industry is in the same range as BDX (70). This means that RMD’s stock grew similarly to BDX’s over the last 12 months.
BDX's Profit vs Risk Rating (78) in the Medical Specialties industry is in the same range as RMD (100). This means that BDX’s stock grew similarly to RMD’s over the last 12 months.
RMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for BDX (85). This means that RMD’s stock grew somewhat faster than BDX’s over the last 12 months.
BDX's Price Growth Rating (9) in the Medical Specialties industry is in the same range as RMD (40). This means that BDX’s stock grew similarly to RMD’s over the last 12 months.
BDX's P/E Growth Rating (7) in the Medical Specialties industry is somewhat better than the same rating for RMD (61). This means that BDX’s stock grew somewhat faster than RMD’s over the last 12 months.
| BDX | RMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 67% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 55% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 55% | 1 day ago 66% |
| MACD ODDS (%) | 1 day ago 50% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 49% | 1 day ago 59% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 60% |
| Advances ODDS (%) | 1 day ago 45% | 1 day ago 57% |
| Declines ODDS (%) | 4 days ago 42% | N/A |
| BollingerBands ODDS (%) | 1 day ago 56% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 49% | 1 day ago 61% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 2 FA rating(s) are green while RMD’s FA Score has 0 green FA rating(s).
- BDX’s FA Score: 2 green, 3 red.
- RMD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 6 TA indicator(s) are bullish while RMD’s TA Score has 7 bullish TA indicator(s).
- BDX’s TA Score: 6 bullish, 4 bearish.
- RMD’s TA Score: 7 bullish, 4 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а +2.89% price change this week, while RMD (@Pharmaceuticals: Other) price change was +4.64% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
Reported Earning Dates
BDX is expected to report earnings on Nov 05, 2026.
RMD is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.74% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | +3.13% | ||
| COO - BDX | 55% Loosely correlated | +4.54% | ||
| TMO - BDX | 50% Loosely correlated | -2.52% | ||
| BAX - BDX | 49% Loosely correlated | +3.85% | ||
| CNMD - BDX | 48% Loosely correlated | +4.95% | ||
| MMSI - BDX | 48% Loosely correlated | +2.78% | ||
More | ||||
RMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, RMD has been loosely correlated with BDX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then BDX could also see price increases.
| Ticker / NAME | Correlation To RMD | 1D Price Change % | ||
|---|---|---|---|---|
| RMD | 100% | +2.79% | ||
| BDX - RMD | 47% Loosely correlated | +3.13% | ||
| BAX - RMD | 47% Loosely correlated | +3.85% | ||
| SOLV - RMD | 42% Loosely correlated | +0.90% | ||
| ISRG - RMD | 41% Loosely correlated | +3.67% | ||
| COO - RMD | 40% Loosely correlated | +4.54% | ||
More | ||||